trending Market Intelligence /marketintelligence/en/news-insights/trending/BtcZibOhgaQAefxKTe0qvA2 content esgSubNav
In This List

Moody's: Pfizer's sale of consumer healthcare business is positive for liquidity

Video

S&P Capital IQ Pro | Unrivaled Sector Coverage

Video

S&P Capital IQ Pro | Powering Your Edge

Blog

Enterprises are missing out on 24B by not optimizing cloud spending not going multicloud

Blog

Investment Research Analysts Providing Greater Coverage on Inflation


Moody's: Pfizer's sale of consumer healthcare business is positive for liquidity

Moody's said a sale by Pfizer Inc. of its consumer healthcare business would have a positive impact on the company's liquidity.

The rating agency believes that Pfizer will have flexibility in deciding how to redeploy the proceeds from the asset sale, which would outweigh the modest loss of earnings and product diversification from the business.

Moody's said the sale of the business does not have any impact on Pfizer's ratings and outlook.